FIELD: medicine.
SUBSTANCE: application describes ACE inhibitor complexes of Perindopril Erbumine with cyclodextrins, polyvinylpyrrolidone or hydroxypropyl cellulose, methods for making thereof, pharmaceutical compositions.
EFFECT: application for treatment of cardiovascular diseases.
19 cl, 23 dwg, 13 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL CRYSTALLINE FORM OF PERINDOPRIL | 2005 |
|
RU2387641C2 |
WATER-SOLUBLE NIMESULID AND L-LYSINE SALT, METHOD OF ITS PREPARING, COMPOSITION BASED ON THEREOF, NIMESULID SALT AQUEOUS SOLUTION, PHARMACEUTICAL COMPOSITION WITH ANTI-INFLAMMATORY ACTIVITY | 1995 |
|
RU2151764C1 |
IMPROVED SOLUBILITY TERPENE GLYCOSIDES | 2011 |
|
RU2586161C9 |
STABILISED AMORPHOUS FORMS OF IMANITIB MESYLATE | 2008 |
|
RU2489149C2 |
INCLUSION COMPLEX OF 3-MORPHOLINOSIDNONIMIN OR SALT THEREOF OR TAUTOMERIC ISOMER THEREOF WITH CYCLODEXTRIN OR ITS DERIVATIVE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION CONTAINING IT, METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING STENOCARDIA AND HEART'S ISCHEMIC DISEASE IN HUMANS | 1991 |
|
RU2107695C1 |
TOSYLATE SALT OF TRANS-N-ISOBUTYL-3-FLUORO-3-[3-FLUORO-4-(PYRROLIDIN-1-YLMETHYL)PHENYL]CYCLOBUTANE CARBOXAMIDE | 2008 |
|
RU2451016C2 |
ROMIDEPSIN SOLID FORMS AND USE THEREOF | 2011 |
|
RU2607634C2 |
PHARMACEUTICAL COMPOSITION FOR ORAL INTAKE | 1998 |
|
RU2192863C2 |
PHARMACEUTICAL PREPARATION | 2017 |
|
RU2760681C2 |
ISETHIONATE SALT OF CDK4 SELECTIVE INHIBITOR | 2004 |
|
RU2317296C2 |
Authors
Dates
2009-11-10—Published
2005-01-13—Filed